N6W

benzo[b][1]benzazepine-11-carboxamide

Created:	2019-11-14
Last modified:	2020-02-26

Find Related PDB Entry
2 entries where N6W is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	30
Chiral Atom Count	0
Bond Count	32
Aromatic Bond Count	12

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	benzo[b][1]benzazepine-11-carboxamide
Systematic Name (OpenEye OEToolkits)	benzo[b][1]benzazepine-11-carboxamide
Formula	C₁₅ H₁₂ N₂ O
Molecular Weight	236.269
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	NC(=O)N1c2ccccc2C=Cc3ccccc13
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N
Canonical SMILES	CACTVS	3.385	NC(=O)N1c2ccccc2C=Cc3ccccc13
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N
InChI	InChI	1.03	InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
InChIKey	InChI	1.03	FFGPTBGBLSHEPO-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00564
Name	Carbamazepine
Groups	approved investigational
Description	Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]
Synonyms	Carbamazepen Carbamazepinum Carbamazepina CBZ 5-Carbamyl-5H-dibenzo(b,f)azepine Carbamazépine Carbamazepine 5-carbamoyl-5H-dibenz[b,f]azepine 5H-Dibenz(b,f)azepine-5-carboxamide 5-Carbamoyl-5H-dibenz(b,f)azepine Carbamazepin Molecusol-Carbamazepine 5-Carbamoyl-5H-dibenzo(b,f)azepine
Brand Names	Apo-carbamazepine CR Taro-carbamazepine CR Mazepine Carbamazepine 200 Tab 200mg Nu-carbamazepine Tab 200mg PHL-carbamazepine CR PMS-carbamazepine-CR Tegretol Dom-carbamazepine PMS-carbamazepine CR Carbamazepine (Chewable) Tegretol XR Taro-carbamazepine Chewable Tablets Taro-carbamazepine Carbamazepine-CR -(400mg) Sandoz-carbamazepine Chewtabs Tegretol CR Carbamazepin Teva-carbamazepine Taro-carbamazepine Tab 200mg CarbamazepineER ER Tegretol Chewtabs 200 mg Carbamazepine ER Equetro Sandoz-carbamazepine CR Tegretol Suspension Tegretol Chewtabs 100 mg Epitol Carbatrol Mint-carbamazepine Dom-carbamazepine CR PMS-carbamazepine Carbamazepine CR carbamazepine ER Apo-carbamazepine Carbamazepine Tegretol - XR Carnexiv Mylan-carbamazepine CR Bio-carbamazepine Carbamazepine 200mg Tablets Carbamazepine-CR -(200mg) TegretolXR XR
Indication	Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]
Categories	Analgesics Analgesics, Non-Narcotic Anticonvulsants Antimanic Agents Carboxamide Derivatives Cardiovascular Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Inducers Cytochrome P-450 CYP1A2 Inducers (strong) Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 CYP2B6 Inducers (strong) Cytochrome P-450 CYP2B6 Substrates Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 CYP2C19 Inducers (moderate) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 CYP2C8 Inducers Cytochrome P-450 CYP2C8 Inducers (strength unknown) Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2C9 Inducers Cytochrome P-450 CYP2C9 Inducers (strength unknown) Cytochrome P-450 CYP3A Inducers Cytochrome P-450 CYP3A Inducers (strong) Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inducers Cytochrome P-450 CYP3A4 Inducers (strong) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A5 Inducers Cytochrome P-450 CYP3A5 Inducers (strength unknown) Cytochrome P-450 CYP3A5 Inducers (strong) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Central Nervous System Disorganized Electrical Activity Dibenzazepines Drugs that are Mainly Renally Excreted Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index Enzyme Inducing Antiepileptic Drugs Heterocyclic Compounds, Fused-Ring Immunosuppressive Agents Inducers of Drug Clearance Membrane Transport Modulators Miscellaneous Anticonvulsants Mood Stabilizer Myelosuppressive Agents Narrow Therapeutic Index Drugs P-glycoprotein inducers P-glycoprotein substrates Peripheral Nervous System Agents Psychotropic Drugs Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Sodium Channel Blockers Thyroxine-binding globulin substrates UGT1A1 Inducers UGT1A6 inducer UGT2B7 substrates UGT2B7 Substrates with a Narrow Therapeutic Index
ATC-Code	N03AF01
CAS number	298-46-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Voltage-gated sodium channel alpha subunit	MEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPK...	unknown	inhibitor
Neuronal acetylcholine receptor subunit alpha-4	MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNK...	unknown	inhibitor
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown	activator
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inducer
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	substrate,inducer
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	inhibitor,inducer
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	inducer
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inhibitor,inducer
Cytochrome P450 2B6	MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG...	unknown	substrate,inducer
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate,inducer
UDP-glucuronosyltransferase 2B7	MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG...	unknown	substrate
UDP-glucuronosyltransferase 1A1	MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL...	unknown	inducer
UDP-glucuronosyltransferase 1A6	MACLLRSFQRISAGVFFLALWGMVVGDKLLVVPQDGSHWLSMKDIVEVLS...	unknown	inducer
UDP-glucuronosyltransferase 1A7	MARAGWTGLLPLYVCLLLTCGFAKAGKLLVVPMDGSHWFTMQSVVEKLIL...	unknown	inducer
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inducer
RalA-binding protein 1	MTECFLPPTSSPSEHRRVEHGSGLTRTPSSEEISPTKFPGLYRTGEPSPP...	unknown	substrate
ATP-binding cassette sub-family C member 2	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL108
PubChem	2554
ChEMBL	CHEMBL108
ChEBI	CHEBI:3387
CCDC/CSD	CBMZPN18, LOFKIB01, CBMZPN23, MOXVIF, LEZKEI01, CBMZPN17, CBMZPN01, CBMZPN12, MOXVOL, FAYYAI, FAYXUB, LEXQAJ, FAYXOV, CBMZPN10, CBMZPN20, LEZKEI, CBMZPN14, CBMZPN22, MOXVIF01, HORWIX, CBMZPN27, MOXVAX, MOXWAY, JIQLAZ, CBMZPN16, HUQWOH, LEXPOW, LEXPIQ, LOFKIB, BIXBOC, CBMZPN11, FEFNOT03, MOXVEB, KIWBOI, MOXWEC, MOXVIF03, KICWOK, JIQLED, FOMXAH, JIQKUS, CBMZPN21, FEFNOT04, CBMZPN03, FEFNOT02, CRBMZA01, ABOQUF, CBMZPN02, EYEJAW, CBMZPN33
COD	1506790, 2019240, 4100977, 2107460, 7106548, 4508997, 4509211, 4509214, 4509213, 4509215, 4509216, 4509217, 4509219, 4509218, 4509220, 4509221, 4509222, 7203285, 2216052, 7216032, 7227180, 4510731, 4510732, 4510733, 2205799, 2205821, 2205976, 2300327, 2300417, 7228537, 7228538, 7228539, 2311081, 2311083, 2311085, 4512302, 4500002, 4500004, 4500003, 4500005, 4500007, 4500008, 4500011, 4500010, 4500012, 1505213, 4502452, 4503359